ArticleFrontiers in oncology2019

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients.

Xia-Hong You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.